Hence, Laucet al. [8] further explored the potential of IKZF1-associated N-glycans as biomarkers for SLE and demonstrated the substantial power of fucosylated bisecting N-glycans to differentiate between healthy controls and SLE patients (AUC=0.842). Here, IKZF1 is linked to systemic lupus erythematosus.